Diabetes awareness month with ITJ

This month, ITJ recognizes Diabetes Awareness

Did you realize that more than 1 in 5 Americans with diabetes are completely unaware of their condition? The American Diabetes Association (ADA) estimates that 7.3 million people don’t know that they have diabetes and all the associated health concerns.

Throughout the nation, communities come together to raise awareness of diabetes during National Diabetes Month in November, and ITJ is no exception. To ensure that more people understand the importance and scope of this disease on a global scale, we want to keep reaching out and talking about it.

Diabetes Treatment through time

Since its first discovery in 1923, insulin has undergone purification and current synthetic production by genetically altered microorganisms. With the use of insulin analogs, kinetics, and repeatability, it was possible to target near-normal glycemia without causing hypoglycemia, already improving patients’ lives. But they were still a long way from the tipping point.

In this scenario, patients with type 1 diabetes and some with type 2 diabetes require daily insulin administration. This also entails urine used for glucose monitoring, with specific glucose monitoring cassettes and Clinitest tablets that boil the urine. Ketones were measured using color-changing tablets. 

Years later, diabetes still requires monitoring several times a day, whether calculating every meal and snack or checking glycemia using whichever method is preferred. Patients must constantly be on the lookout for symptoms of hypoglycemia. This amount of diligence is uncommon under other circumstances. Throughout the history of contemporary diabetes management, this fact has not altered. 

Since the discovery of insulin and the development of pure clinical diagnosis, diabetes management has undergone significant advancements. Now, with the technological era, there have been several life sciences innovations for making the lives of diabetes patients easier. 

Today, a multifaceted approach is used to manage insulin levels. Aside from food restrictions, increased physical activity, lifestyle changes, weight loss, and medication, there is one big life-changer: medical devices.

If you want to learn more about diabetes treatments, visit The Future of Diabetes Treatment.

The medical devices are oriented to help diabetes patients with real-time continuous glucose monitoring. This enables accurate timing of insulin pump administration without the need for finger punctures. Plus, smart insulin delivery systems automate insulin administration increasing accuracy. 

The new technological advancements have eliminated the painful and annoying tasks involved in living with diabetes a few years ago. Now there is a whole new world in the Bio MedTech industry, companies that want to continue to provide solutions that make diabetes patients’ lives easier. 

At ITJ, we continue  our mission of empowering our partners to deliver digital innovation that improves people’s lives. We are committed to helping companies solve problems like diabetes so more people can live their lives freely and without discomfort.

About ITJ

ITJ is devoted to serving fast-growing and high-value market sectors, particularly the Internet of Medical Things (IoMT), working with innovative medical device companies looking to improve people’s lives. With a unique BOT (build, operate, and transfer) model that sources only the best digital talent available, ITJ enables companies in the US to create technology centers of excellence in Mexico. For more information, visit www.itj.com.

Diabetes wallpaper

The future of diabetes treatment

More than 130 million adults are living with diabetes or prediabetes in the US as of January 2022. The latent danger this metabolic condition represents for so many people around the world is unprecedented, and people expect enhanced and innovative treatment methods.

New technologies are being developed to build diabetes devices that improve patients’ lives. For instance, continuous glucose monitoring, mobile apps that count food volume and carbohydrate levels, and insulin pumps. Easing pain and improving dosing precision are just some goals of future diabetes devices. Innovation in the area continues, and many more patients can soon access the newly available technology. 

Some aspects of this process can be aided by technology like the following:

Diabetes Devices

People with diabetes today witness technology for the first time that allows healthcare companies to operate their medical equipment via mobile apps, including remote insulin dosage. This feature has been hinted at for many years but has yet to be approved for use in diabetic devices by the Food and Drug Administration (FDA). Nevertheless, the advances continue, and the diabetes devices available in the market are:

All-in-one-Devices

MIT and Brigham and Women’s Hospital researchers are developing an app that recognizes and quantifies food composition, benefiting diabetics in carbohydrate counting.

The first gadget consists of a lancet, glucose test strips, and an insulin needle. Users would first take a photo of their meal with a smartphone app to assess the food amount and carbohydrate levels. They would then begin the automated process of taking blood, calculating glucose through the app, and providing the correct insulin dose.

The second device requires one needle poke, which includes the glucose sensor into the insulin needle and administers the necessary quantity of insulin. It has a waiting time of 5 to 10 seconds.

IoMT for Diabetes

The rise of the Internet of Medical Things (IoMT) in the industry allows continuous, remote, and real-time patient monitoring. IoMT technology connects patients and physicians via medical devices, providing remote access to gather, process, and send medical data via a secure network. Additionally, these technologies help reduce needless hospital stays and related health expenses by enabling wireless monitoring of health indicators.

The innovation in the healthcare and life sciences sector has reached treatments for diabetes, including software features such as dosage assistance, information, and reminders to aid users in making better health decisions based on their device readings.

The IoT in healthcare is one of the fastest-growing sectors, predicted to reach $176 billion by 2026. And the new goal for 2023 is to expand diabetes device use and include more people with type 2 diabetes in their treatments.

Adopting diabetic technology and new treatments will help what the World Health Organization considers to be an epidemic expected to affect 700 million people by 2045. With the aid of technology and innovative treatments, like the all-in-one device, doctors can reduce diabetes complications and other problems. Finding new routes to improve patients’ lives and technology implemented to facilitate processes has now become imperative. By doing so, a greater number of individuals may be helped, and the application of IoMT in diabetic operations is ushered into a better new tech environment.

For more information about the IoMT and what it is, visit IoMT and Medical Device Cybersecurity.

About ITJ

ITJ is devoted to serving fast-growing and high-value market sectors, particularly the Internet of Medical Things (IoMT), working with innovative medical device companies looking to improve people’s lives. With a unique BOT (build, operate, and transfer) model that sources only the best digital talent available, ITJ enables companies in the US to create technology centers of excellence in Mexico. For more information, visit www.itj.com.